Related Experiment Video
Updated: May 28, 2026
08:13
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Anticoagulation for venous thromboembolism: what if they bleed?
1Dept. of Angiology & Blood Coagulation, University Hospital of Bologna, Bologna, Italy. gualtiero.palareti@unibo.it
Hamostaseologie
|October 20, 2011
Summary
Acute venous thromboembolism (VTE) management involves anticoagulation, with decisions on treatment duration and bleeding management depending on bleeding severity and recurrence risk. Prothrombin complex concentrate is an efficient reversal agent for major bleeding.
Area of Science:
- Hematology
- Cardiology
- Internal Medicine
Background:
- Acute venous thromboembolism (VTE) necessitates anticoagulation therapy.
- Treatment duration for secondary VTE prevention remains under discussion.
- Bleeding risk assessment is crucial for managing anticoagulation.
Purpose of the Study:
- To outline current strategies for managing acute VTE.
- To discuss the duration of anticoagulation for secondary prevention.
- To detail approaches for managing bleeding events during anticoagulation.
Main Methods:
- Review of current guidelines and clinical practices for VTE treatment.
- Assessment of factors influencing anticoagulation duration.
- Evaluation of management strategies for bleeding complications.
Main Results:
- Standard treatment involves heparin followed by vitamin K antagonists (VKAs) to maintain INR 2.0-3.0.
- Management of bleeding depends on type (major/minor) and thrombotic risk.
- Prothrombin complex concentrate is a preferred, efficient reversal agent for major bleeding compared to fresh frozen plasma.
Conclusions:
- Anticoagulation is standard for acute VTE, with individualized duration for secondary prevention.
- Bleeding management requires careful risk-benefit assessment.
- Prompt and effective reversal agents like prothrombin complex concentrate are vital for major bleeding events.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...